Misplaced Pages

Michael H. Gelb

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
For other people named Michael Gelb, see Michael Gelb (disambiguation).
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article includes a list of general references, but it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (January 2011) (Learn how and when to remove this message)
This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous.
Find sources: "Michael H. Gelb" – news · newspapers · books · scholar · JSTOR (January 2011) (Learn how and when to remove this message)
(Learn how and when to remove this message)
Michael H. Gleb
Born1957 (age 67–68)
NationalityAmerican
EducationUniversity of California, Davis, Yale University (PhD)
Known forRoutine newborn screening of lysosomal storage diseases
AwardsGustavus John Esselen Award of the American Chemical Society
Scientific career
FieldsChemistry and biochemistry
InstitutionsUniversity of Washington
Doctoral advisorStephen G. Sliga

Professor Michael H. Gleb (born 1957) is an American biochemist and chemist specializing in enzymes and particularly those of medical significance. He is the Boris and Barbara L. Weinstein Endowed Chair in Chemistry at the University of Washington in Seattle. He also teaches Honors Organic Chemistry, Chemical Biology and Enzymology.

Education

This section needs expansion. You can help by adding to it. (January 2011)

Gelb studied chemistry and biochemistry at the University of California, Davis before taking a Ph.D under Stephen G. Sligar at Yale University on aspects of the catalytic mechanism of cytochrome P450. Granted an American Cancer Society postdoctoral fellowship, he then investigated mechanism-based inactivators of serine proteases and developed fluorinated ketones as tight-binding inhibitors of several classes of proteases, working with Robert H. Abeles at Brandeis University.

Professional life

Since 1985 Gleb has been a faculty member at the University of Washington in the Departments of Chemistry and Biochemistry.

In order to investigate enzymatic processes of biomedical importance, the Gelb laboratory employs a variety of methods from molecular and cellular biochemistry as well as synthetic organic chemistry. Major accomplishments from the Gelb laboratory include: 1) The discovery of protein isoprenylation in the late 1980s (together with Professor John Glomset); 2) The development of methods to analyze enzymes that work on membrane surfaces (together with Professors Mahendra Jain and Otto Berg); 3) The development of Isotope-Coded Affinity Tags for quantitative proteomics (together with Professors Ruedi Aebersold and Frank Turecek); 4) The development of tandem mass spectrometry for newborn screening of enzyme deficiency diseases (together with Professors Frank Turecek and C. Ronald Scott). Routine newborn screening of lysosomal storage diseases using technology developed in the Gelb laboratory was brought into use in New York state in 2006 . Plans are underway to expand screening in other regions of the US and in several other countries.

His current research interests include: 1) Studying the function and regulation of a group of enzymes called phospholipase A2 that are involved in lipid mediator biosynthesis related to inflammation; 2) Anti-malaria and anti-trypanosome drug discovery; 3) New technology for the newborn screening of enzyme deficiency diseases including lysosomal storage diseases.

Awards

Gelb's awards include:

Notes and references

  1. Farnsworth, Christopher C.; Gelb, Michael H.; Glomset, John A. (19 January 1990). "Identification of Geranylgeranyl-Modified Proteins in HeLa Cells". Science. 247 (4940): 320–322. doi:10.1126/science.2296721. PMC 3442113.
  2. Gelb, Michael H.; Jain, Mahendra K.; Hanel, Arthur M.; Berg, Otto G. (June 1995). "INTERFACIAL ENZYMOLOGY OF GLYCEROLIPID HYDROLASES: Lessons from Secreted Phospholipases A 2". Annual Review of Biochemistry. 64 (1): 653–688. doi:10.1146/annurev.bi.64.070195.003253.
  3. Gygi, Steven P.; Rist, Beate; Gerber, Scott A.; Turecek, Frantisek; Gelb, Michael H.; Aebersold, Ruedi (October 1999). "Quantitative analysis of complex protein mixtures using isotope-coded affinity tags". Nature Biotechnology. 17 (10): 994–999. doi:10.1038/13690.
  4. Li, Yijun; Scott, C Ronald; Chamoles, Nestor A; Ghavami, Ahmad; Pinto, B Mario; Turecek, Frantisek; Gelb, Michael H (1 October 2004). "Direct Multiplex Assay of Lysosomal Enzymes in Dried Blood Spots for Newborn Screening". Clinical Chemistry. 50 (10): 1785–1796. doi:10.1373/clinchem.2004.035907. PMC 3428798.
  5. Duffner, Patricia K.; Caggana, Michele; Orsini, Joseph J.; Wenger, David A.; Patterson, Marc C.; Crosley, Carl J.; Kurtzberg, Joanne; Arnold, Georgianne L.; Escolar, Maria L.; Adams, Darius J.; Andriola, Mary R.; Aron, Alan M.; Ciafaloni, Emma; Djukic, Alexandra; Erbe, Richard W.; Galvin-Parton, Patricia; Helton, Laura E.; Kolodny, Edwin H.; Kosofsky, Barry E.; Kronn, David F.; Kwon, Jennifer M.; Levy, Paul A.; Miller-Horn, Jill; Naidich, Thomas P.; Pellegrino, Joan E.; Provenzale, James M.; Rothman, Stanley J.; Wasserstein, Melissa P. (April 2009). "Newborn Screening for Krabbe Disease: the New York State Model". Pediatric Neurology. 40 (4): 245–252. doi:10.1016/j.pediatrneurol.2008.11.010.

External links

Pfizer Award in Enzyme Chemistry
Formerly the Paul-Lewis Award in Enzyme Chemistry
Repligen Corporation Award in Chemistry of Biological Processes
Categories:
Michael H. Gelb Add topic